Characterization, prognosis, and treatment of patients with head & neck well-differentiated neuroendocrine tumors – A retrospective study of the French GTE-ENDOCAN RENATEN and REFCOR networks
#3625
Introduction: Head & neck well-differentiated neuroendocrine tumors (HN NET) are rare, locally aggressive, and barely known tumors compared to HN neuroendocrine carcinoma.
Aim(s): To characterize HN NET and their therapeutic management, to evaluate prognostic factors and to identify potential specificities compared to other NET.
Materials and methods: Retrospective study in 10 expert centers of the French GTE and REFCOR networks.
Conference:
Presenting Author: Boilève A
Authors: Boilève A, Camby S, Morinière S, Le Bras M, Vérillaud B,
Keywords: Head & neck tumor, carcinoid tumor, well-differentiated net, prognosis, treatment,
To read the full abstract, please log into your ENETS Member account.